Company:  TYME TECHNOLOGIES, INC. (TYME)
Form Type:  8-K
Filing Date:  6/23/2022 
CIK:  0001537917 
Address:  1 PLUCKEMIN WAY - SUITE 103 
City, State, Zip:  BEDMINSTER, New Jersey 07921 
Telephone:  212-461-2315 
Fiscal Year:  03/31 
Last Trade
Last Trade: 
$0.33  
Change: 
0.02 (6.48%)  
Trade Time: 
Aug 10  
Market Cap: 
$56.66M
Trade TYME now with 

© 2022  
Description of Business
TYME is an emerging biotechnology company developing CMBTs that are intended to be effective across a broad range of solid tumors and hematologic cancers, while also maintaining patients' quality of life through relatively low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic requirements to cause cancer cell death. The Company is currently focused on developing its novel compound, SM-88, as well as further evaluating its preclinical pipeline of novel CMBTTM programs, and TYME-19 as a potential therapeutic for SARS CoV-2 diseases. The Company believes that early clinical results demonstrated by SM-88 in multiple advanced cancers, including breast, sarcomas, pancreatic, and prostate, reinforce the potential of its emerging CMBT(TM) pipeline.
Register and access this filing in:     
  FORM 8-K
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.01. Notice of Delisting or Failure to Satisfy a ...
    SIGNATURES